These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15095207

  • 1. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N, Ziran BH, Wagener MM, Santa ER, Yu VL.
    Clin Infect Dis; 2004 Apr 15; 38(8):1058-64. PubMed ID: 15095207
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
    Rao N, Hamilton CW.
    Diagn Microbiol Infect Dis; 2007 Oct 15; 59(2):173-9. PubMed ID: 17574788
    [Abstract] [Full Text] [Related]

  • 3. Hematologic effects of linezolid in young children.
    Meissner HC, Townsend T, Wenman W, Kaplan SL, Morfin MR, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 15; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [Abstract] [Full Text] [Related]

  • 4. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA, Shorr AF, Kuter DJ, O'Grady N, Le VH, Cammarata SK.
    Clin Infect Dis; 2003 Dec 15; 37(12):1609-16. PubMed ID: 14689341
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ.
    Clin Infect Dis; 2006 Mar 01; 42(5):597-607. PubMed ID: 16447103
    [Abstract] [Full Text] [Related]

  • 6. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA, Deville J, Adler S, Morfin MR, Lopez P, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 01; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH, Tack KJ, Bouza E, Herr DL, Ruf BR, Ijzerman MM, Croos-Dabrera RV, Kunkel MJ, Knirsch C.
    Clin Infect Dis; 2009 Jan 15; 48(2):203-12. PubMed ID: 19072714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
    Sirvent JM, Piñeiro L, de la Torre M, Motjé M, de Batlle J, Bonet A.
    Rev Esp Quimioter; 2010 Mar 15; 23(1):27-35. PubMed ID: 20232021
    [Abstract] [Full Text] [Related]

  • 14. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 15; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [Abstract] [Full Text] [Related]

  • 15. Haematological safety of long-term therapy with linezolid.
    Garazzino S, De Rosa FG, Bargiacchi O, Audagnotto S, Maiello A, Di Perri G.
    Int J Antimicrob Agents; 2007 Apr 15; 29(4):480-3. PubMed ID: 17317112
    [No Abstract] [Full Text] [Related]

  • 16. Hematologic effects of linezolid versus vancomycin.
    Young LS.
    Clin Infect Dis; 2004 Apr 15; 38(8):1065-6. PubMed ID: 15095208
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I, Konkoly TM, Zsirka KA, Csapó Z, Flautner L, Tihanyi T.
    Orv Hetil; 2003 Jan 05; 144(1):29-33. PubMed ID: 12635350
    [Abstract] [Full Text] [Related]

  • 20. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC, Wang YT, Wang CY, Tsai IJ, Wu KD, Hwang JJ, Hsueh PR.
    Clin Infect Dis; 2006 Jan 01; 42(1):66-72. PubMed ID: 16323094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.